Cognitive Dysfunction Following Cardiac Surgery

NCT ID: NCT02767713

Last Updated: 2016-05-10

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE4
• Total Enrollment: 171 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-03-31
• Study Completion Date: 2016-12-31

Brief Summary

Postoperative cognitive dysfunction (POCD) is the most common complication after cardiac surgery. This prospective study was conducted to investigate the mechanisms of development of POCD following cardiac surgery taking into account surgical technique (with use or no use of extracorporeal circulation). The investigators focused on the role of inflammatory and stress response to surgical procedure as potential factors involved in the pathogenesis of cognitive dysfunction. Systematic inflammatory response in patients undergoing on-pump or off-pump surgery was analyzed by measuring serum levels of C reactive protein (CRP) and occurrence of systemic inflammatory response syndrome (SIRS). Stress response to surgery was evaluated following cortisol levels and its daily variations. The degree of cognitive dysfunction was assessed based on serum levels of S100β. The effect of dexamethasone on the levels of stress and inflammatory response biomarkers, serum levels of S100β, as well as on the development of POCD was compared with control group that received normal saline.

Detailed Description

This is a prospective, randomized, double blind, controlled trial. Following detailed past medical history assessment, two days before the surgical procedure neurocognitive function tests, depression and anxiety tests were carried out to assess the participants. Neurocognitive and anxiety tests were repeated on the 6th day after surgical procedure. A battery of tests lasting approximately 40 minutes were administered by a trained neuropsychologist from the Clinical Hospital Center, Split in a standardized fashion, at the same time of the day (10:00 AM) and in the same room at the Cardiac surgery ward. The investigators used a validated battery of tests which enabled the assessment of psychomotor speed, visual-motor coordination, concentration, attention, short-term memory and aspects of executive functioning. The evaluation was based on the following tests: Mini Mental State Examination (MMSE), Wechsler Memory Scale (WMS I & II), Trail Making Test (TMT A & B), Symbol Digit Modalities Test (SDMT), Controlled Oral Word Association Test (COWAT) and PsychE computer test. All of the tests except TMT A & B have alternate forms. Croatian versions of Beck Depression Inventory-Second Edition (BDI II) and State-Trait Anxiety Inventory (STAI-M) were used for preoperative depression and trait and state anxiety assessment, respectively.

One day before the surgery (08:00 AM) blood samples were collected for determination of levels of S100β protein, cortisol and other routine laboratory parameters (white blood cell count (WBC), hematocrit, creatinine, glucose, albumin, sodium, potassium, C reactive protein (CRP), Troponin I hs).

Participants were randomized into two groups to receive either intravenous dexamethasone 0.1 mg/kg or the same volume of normal saline i.v. 10 hours before the surgery. Random sequence generator was used to determine participant allocation.

Anesthesia in all patients was based on fentanyl, midazolam, vecuronium and sevoflurane. The depth of anesthesia was monitored using bispectral index (BIS). During cardiopulmonary bypass alpha-stat technique was used with the maintenance of normothermia (35.5-36.5°C) or spontaneous hypothermia (up to 32°C). With the off-pump technique, the core temperature was maintained between 36 and 37°C. Surgical technique was standardized. Routine hemodynamic monitoring was performed throughout the surgery and continued on the first postoperative day. Plasma levels of S100β protein were determined 6 h and 30 h following the end of on-pump surgery, and 3 h following the end of off-pump surgery. C reactive protein levels and other routine laboratory parameters were measured from blood samples collected 1 h, 4 h and 12 h postoperatively. On the first postoperative day blood samples were collected at 08:00 AM to determine cortisol levels, C reactive protein and other routine laboratory parameters, and cortisol was also measured on the same day at 04:00 PM, and 12:00 AM. C reactive protein and other routine laboratory parameters were repeatedly measured at 08:00 AM on the following postoperative days, except for cortisol levels which were measured on postoperative days 3 and 5. Registered nurse carried out the standardized test (Delirium Observation Screening Scale (DOS) scale) to assess the patients for the development of postoperative delirium from second to fifth postoperative day (at 07:00 AM, 02:00 PM and 10:00 PM).

Conditions

Postoperative Cognitive Dysfunction

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: TRIPLE

Study Groups

Dexamethasone

Dexamethasone dose of 0.1 mg/kg was administered intravenously 10h before surgery

Group Type: EXPERIMENTAL

Dexamethasone

Intervention Type: DRUG

Intravenous dexamethasone (0.1 mg/kg) was administered 10 hours before surgery.

Control

Equal volume of normal saline (placebo) was administered intravenously 10h before surgery

Group Type: PLACEBO_COMPARATOR

Placebo

Intervention Type: OTHER

Normal saline (placebo) in the equal volume as active treatment was administered 10 hours before surgery.

Interventions

Dexamethasone

Intravenous dexamethasone (0.1 mg/kg) was administered 10 hours before surgery.

Intervention Type: DRUG

Placebo

Normal saline (placebo) in the equal volume as active treatment was administered 10 hours before surgery.

Intervention Type: OTHER

Other Intervention Names

Dexasone; Inactive substance

Eligibility Criteria

Inclusion Criteria

• Participants undergoing cardiac surgery: coronary artery bypass grafting, heart valve surgery or a combined procedure,
• Procedure must be elective

Exclusion Criteria

• Symptomatic cerebrovascular disease,
• Cerebrovascular incident in last 3 years,
• Neurodegenerative disease,
• Psychiatric disease,
• Visual, hearing or motor impairment interfering with cognitive testing,
• Carotid artery stenosis ( ≥50%),
• Myocardial infarction within last 3 months,
• Left ventricular ejection fraction of ≤35%,
• Previous cardiac or carotid surgery,
• Uncontrolled systemic hypertension (blood pressure≥180/110 mmHg),
• Corticosteroid-dependent asthma,
• Chronic obstructive pulmonary disease (COPD),
• Malignancy, liver disease (aspartate transaminase (AST), alanine transaminase (ALT) or bilirubin ˃1.5x above reference range),
• Kidney disease (serum creatinine ˃1.7 mg/dl or blood urea nitrogen ˃50 mg/dL),
• Uncontrolled diabetes mellitus (postprandial glucose ˃200 mg/dL or hemoglobin A1c ˃9%),
• Endocrine and metabolic diseases, requiring steroid treatment longer than 7 days in the past year,
• Alcohol or controlled substance abuse,
• Individuals without primary school education,
• Preoperative C reactive protein ˃0.5 mg/dL,
• Preoperative white blood cell count <3 x109/L or ˃11 x109/L,
• Preoperative Mini mental score <26 points,
• Preoperative Beck's depression inventory score ˃ 19 points,
• Intraoperative plan change (conversion from "off-pump" to "on-pump" and vice versa),
• Need for deep hypothermic circulatory arrest,
• Additional corticosteroid treatment throughout the study period.

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Clinical Hospital Center, Split

OTHER

Sponsor Role: lead

Responsible Party

Sandro Glumac

MD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Nenad Karanovic, MD, PhD

Role: STUDY_DIRECTOR

Clinical Hospital Center, Split

References

Ottens TH, Dieleman JM, Sauer AM, Peelen LM, Nierich AP, de Groot WJ, Nathoe HM, Buijsrogge MP, Kalkman CJ, van Dijk D; DExamethasone for Cardiac Surgery (DECS) Study Group. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial. Anesthesiology. 2014 Sep;121(3):492-500. doi: 10.1097/ALN.0000000000000336.

Reference Type: BACKGROUND

PMID: 25225745 (View on PubMed)

Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001 Feb 8;344(6):395-402. doi: 10.1056/NEJM200102083440601.

Reference Type: BACKGROUND

PMID: 11172175 (View on PubMed)

Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996 Dec 19;335(25):1857-63. doi: 10.1056/NEJM199612193352501.

Reference Type: BACKGROUND

PMID: 8948560 (View on PubMed)

Hudetz JA, Gandhi SD, Iqbal Z, Patterson KM, Pagel PS. Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J Anesth. 2011 Feb;25(1):1-9. doi: 10.1007/s00540-010-1042-y.

Reference Type: BACKGROUND

PMID: 21061037 (View on PubMed)

Rasmussen LS, O'Brien JT, Silverstein JH, Johnson TW, Siersma VD, Canet J, Jolles J, Hanning CD, Kuipers HM, Abildstrom H, Papaioannou A, Raeder J, Yli-Hankala A, Sneyd JR, Munoz L, Moller JT; ISPOCD2 Investigators. Is peri-operative cortisol secretion related to post-operative cognitive dysfunction? Acta Anaesthesiol Scand. 2005 Oct;49(9):1225-31. doi: 10.1111/j.1399-6576.2005.00791.x.

Reference Type: BACKGROUND

PMID: 16146456 (View on PubMed)

Mu DL, Li LH, Wang DX, Li N, Shan GJ, Li J, Yu QJ, Shi CX. High postoperative serum cortisol level is associated with increased risk of cognitive dysfunction early after coronary artery bypass graft surgery: a prospective cohort study. PLoS One. 2013 Oct 15;8(10):e77637. doi: 10.1371/journal.pone.0077637. eCollection 2013.

Reference Type: BACKGROUND

PMID: 24143249 (View on PubMed)

Phillips-Bute B, Mathew JP, Blumenthal JA, Grocott HP, Laskowitz DT, Jones RH, Mark DB, Newman MF. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med. 2006 May-Jun;68(3):369-75. doi: 10.1097/01.psy.0000221272.77984.e2.

Reference Type: BACKGROUND

PMID: 16738066 (View on PubMed)

Jensen BO, Hughes P, Rasmussen LS, Pedersen PU, Steinbruchel DA. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial. Circulation. 2006 Jun 20;113(24):2790-5. doi: 10.1161/CIRCULATIONAHA.105.587931. Epub 2006 Jun 12.

Reference Type: BACKGROUND

PMID: 16769915 (View on PubMed)

Parolari A, Camera M, Alamanni F, Naliato M, Polvani GL, Agrifoglio M, Brambilla M, Biancardi C, Mussoni L, Biglioli P, Tremoli E. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg. 2007 Sep;84(3):823-8. doi: 10.1016/j.athoracsur.2007.04.048.

Reference Type: BACKGROUND

PMID: 17720383 (View on PubMed)

Canet J, Raeder J, Rasmussen LS, Enlund M, Kuipers HM, Hanning CD, Jolles J, Korttila K, Siersma VD, Dodds C, Abildstrom H, Sneyd JR, Vila P, Johnson T, Munoz Corsini L, Silverstein JH, Nielsen IK, Moller JT; ISPOCD2 investigators. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand. 2003 Nov;47(10):1204-10. doi: 10.1046/j.1399-6576.2003.00238.x.

Reference Type: BACKGROUND

PMID: 14616316 (View on PubMed)

Ernest CS, Worcester MU, Tatoulis J, Elliott PC, Murphy BM, Higgins RO, Le Grande MR, Goble AJ. Neurocognitive outcomes in off-pump versus on-pump bypass surgery: a randomized controlled trial. Ann Thorac Surg. 2006 Jun;81(6):2105-14. doi: 10.1016/j.athoracsur.2006.01.008.

Reference Type: BACKGROUND

PMID: 16731138 (View on PubMed)

Glumac S, Kardum G, Sodic L, Bulat C, Covic I, Carev M, Karanovic N. Longitudinal assessment of preoperative dexamethasone administration on cognitive function after cardiac surgery: a 4-year follow-up of a randomized controlled trial. BMC Anesthesiol. 2021 Apr 23;21(1):129. doi: 10.1186/s12871-021-01348-z.

Reference Type: DERIVED

PMID: 33892653 (View on PubMed)

Glumac S, Kardum G, Sodic L, Supe-Domic D, Karanovic N. Effects of dexamethasone on early cognitive decline after cardiac surgery: A randomised controlled trial. Eur J Anaesthesiol. 2017 Nov;34(11):776-784. doi: 10.1097/EJA.0000000000000647.

Reference Type: DERIVED

PMID: 28985195 (View on PubMed)

Other Identifiers

SPLIT1984

Identifier Type: -

Identifier Source: org_study_id